Systematic Review
Accepted on 17 Nov 2025
Reduced versus Standard Dose Apixaban for Secondary Prevention of Cancer-Associated Venous Thromboembolism: A Pooled Analysis of Two Randomized Controlled Trials
in Cardio-Oncology
- 126 views
Systematic Review
Accepted on 17 Nov 2025
in Cardio-Oncology
Original Research
Accepted on 17 Nov 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Original Research
Accepted on 17 Nov 2025
in Cancer Immunity and Immunotherapy
Editorial
Accepted on 17 Nov 2025
in Political Participation
Correction
Accepted on 17 Nov 2025
in Maternal Health
Original Research
Accepted on 17 Nov 2025
in Organizational Psychology
Original Research
Accepted on 17 Nov 2025
in Animal Behavior and Welfare
Original Research
Accepted on 17 Nov 2025
in Psycho-Oncology
Original Research
Accepted on 17 Nov 2025
in Ethnopharmacology
Systematic Review
Accepted on 17 Nov 2025
in Adolescent and Young Adult Psychiatry
Original Research
Accepted on 17 Nov 2025
in Social Psychiatry and Psychiatric Rehabilitation
Review
Accepted on 17 Nov 2025
in Psychological Therapy and Psychosomatics
Systematic Review
Accepted on 17 Nov 2025
in Head and Neck Cancer
Original Research
Accepted on 17 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 17 Nov 2025
in Infectious Diseases: Pathogenesis and Therapy
Original Research
Accepted on 17 Nov 2025
in Cancer Immunity and Immunotherapy